Health Law Alliance

Enforcement of Arbitration Clauses in PBM Network Agreements: A Guide for Pharmacy Owners: This article explains arbitration clauses in Pharmacy Benefit Manager (PBM) network agreements, outlining when these clauses can be enforced and how they affect dispute resolution for pharmacies. https://lnkd.in/exKMVR5Q

Triumph Over Optum: HLA’s Tenacious Advocacy Reverses Optum’s Termination of a Texas Pharmacy: Health Law Alliance successfully reversed Optum’s termination of a Texas pharmacy from its network, protecting the pharmacy from severe financial and reputational damage. Our healthcare attorneys used strategic legal expertise and negotiations to overturn the decision, ensuring the pharmacy could continue serving patients. This victory highlights our dedication to strong advocacy and proven results. https://lnkd.in/dBdPcZJ5

HLA's Lawsuit Against Optum Achieves Return of Hundreds of Thousands of Dollars in Withheld Reimbursement: Health Law Alliance's lawsuit against Optum has resulted in the immediate release of hundreds of thousands of dollars in reimbursement that Optum unlawfully refused to release to our client prior to being sued. https://lnkd.in/eQPJjyZS

HLA Convinces Optum to Reverse PBM Audit Termination: Health Law Alliance is pleased to announce that Optum recently agreed to reverse its network termination of a Texas pharmacy client despite significant claim discrepancies based on inventory shortages, patient denials, and other alleged violations of the terms and conditions of the Provider Manual and network enrollment agreements. https://lnkd.in/dcfcmf4b

A Golden Opportunity for Compounding Pharmacies: Navigating the Ozempic Shortage: There has never been a more fortunate time for compounding pharmacies looking to capitalize on the "Gold Rush" of Ozempic. Due to the forecasted limited supply of the brand name drug, the FDA has put Ozempic on the shortage list, which will allow for a more accommodating set of rules regarding compounding and distribution of semaglutide-based drugs. https://lnkd.in/e5b5Eh5Y

Pharmacy Benefit Managers (PBMs) Face Possible FTC Lawsuit: The Federal Trade Commission (FTC) plans to sue the top Pharmacy Benefit Managers (PBMs) for anti-competitive practices, including influencing drug prices and favoring their own networks, which disadvantage independent pharmacies and raise prescription drug costs. https://lnkd.in/eAuXbwvu

HLA Files Emergency Texas Lawsuit Against Optum PBM Audit Termination: Health Law Alliance announces the filing of an emergency lawsuit in federal court for the Northern District of Texas, Dallas Division, to stop Optum's termination of an independent pharmacy. https://lnkd.in/eaJwA4gG

Victories Against Optum Rx: Protecting Pharmacy Clients Nationwide: Health Law Alliance has successfully challenged Optum Rx's termination decisions for numerous pharmacies, ensuring they can continue to operate and serve their communities. These victories highlight the firm's expertise in healthcare law and its dedication to protecting pharmacy clients from unjust PBM actions. https://lnkd.in/efngm2na

Breaking News: FTC Issues Interim Report Condemning Anticompetitive PBM Practices: The top Pharmacy Benefit Managers (PBMs) are condemned by the FTC for manipulating the healthcare system to generate significant profits, thereby inflating drug costs and overcharging patients, particularly for critical medications like cancer drugs. https://lnkd.in/eMZngbvZ

Federal Prosecutors Focus on Ozempic Violations: Intense semaglutide demand has now drawn the attention of regulators beyond the Food & Drug Administration (FDA) and state boards. Last month, a woman was charged by federal prosecutors with violations of criminal law related to misbranded and adulterated weight loss drugs. This prosecution marks the first of many to come. https://lnkd.in/ewkdHRSh